About Shuguang Zhang
Shuguang Zhang is a research affiliate at the MIT Media Lab. He is a co-founder of the biotech company 511 Therapeutics, and an executive officer and director there. 511 is meant to commercialize the QTY Code, a method he invented in 2011 to design proteins, especially membrane proteins, that become water-soluble.
He founded the biotech company 3-D Matrix in 2002, and it went public in October 2011. He co-founded the Molecular Frontiers Foundation and serves on its board. He earned a bachelor's degree at Sichuan University in China. His doctorate in biochemistry and molecular biology is from the University of California at Santa Barbara. He won the 2006 Wilhelm Exner Medal of Austria.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Shuguang Zhang in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Shuguang Zhang works with at each company, as listed on that company's latest Form D.